AJR Custom publishing of AJR articles and ARRS Cat. Course
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taupitz, M.
Right arrow Articles by Pfefferer, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taupitz, M.
Right arrow Articles by Pfefferer, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 161, 193-200, Copyright © 1993 by American Roentgen Ray Society

ARTICLES

Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits

M Taupitz, S Wagner, B Hamm, A Binder and D Pfefferer
Department of Radiology, Klinikum Steglitz, Freie Universitat Berlin, Germany.

OBJECTIVE. MR lymphography with interstitial injection of superparamagnetic iron oxide particles was optimized in normal rabbits by investigating the pattern of signal reduction in lymph nodes as a function of dose and time after administration. The optimized examination procedure was then used in a rabbit tumor model to study the potential of superparamagnetic iron oxide--enhanced MR lymphography in the detection of metastatic lymph node involvement. MATERIALS AND METHODS. The popliteal and iliac lymph nodes of 18 normal rabbits were imaged to study the dose response and time course of the effect of the contrast agent. For the dose response study, six doses of 2-50 mumol of iron per extremity were administered to three animals per dose, and MR images were obtained before and 12 hr after administration. For the time course study, 20 mumol of iron per extremity was administered to four animals, and images were obtained before and 6 hr to 42 days after administration. VX2 tumor-bearing rabbits were examined 12 hr after administration of 20 mumol (10 animals) and 50 mumol (three animals) of iron per extremity. Superparamagnetic iron oxide was injected into the foot pad of the hind limb. T1-, T2-, and proton density-weighted MR images were obtained with a 1.5-T unit. RESULTS. In normal rabbits, a profound and homogeneous loss of signal intensity was found with doses of 2-5 mumol of iron per extremity in popliteal lymph nodes and with doses of 20-30 mumol in the iliac lymph nodes. Superparamagnetic iron oxide caused maximal loss of signal intensity in both popliteal and iliac lymph nodes 12 hr after administration. In tumor-bearing rabbits, different degrees of metastatic displacement of lymph nodes were discernible, and even small metastases (3 mm in diameter) could be visualized when using the optimized examination protocol and the proton density-weighted spin-echo sequence. CONCLUSION. We conclude that interstitial MR lymphography with superparamagnetic iron oxide enables the detection of lymph node metastases and therefore is a promising technique for improved diagnostic imaging of lymph nodes in the staging of tumors.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 RadiologyHome page
S. K. Verma, D. G. Mitchell, D. Bergin, R. Mehta, S. Chopra, and D. Choi
The Cisterna Chyli: Enhancement on Delayed Phase MR Images after Intravenous Administration of Gadolinium Chelate
Radiology, September 1, 2007; 244(3): 791 - 796.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Kobayashi, S. Kawamoto, R. A. Star, T. A. Waldmann, Y. Tagaya, and M. W. Brechbiel
Micro-magnetic Resonance Lymphangiography in Mice Using a Novel Dendrimer-based Magnetic Resonance Imaging Contrast Agent
Cancer Res., January 15, 2003; 63(2): 271 - 276.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
C. U. Herborn, T. C. Lauenstein, F. M. Vogt, R. B. Lauffer, J. F. Debatin, and S. G. Ruehm
Interstitial MR Lymphography with MS-325: Characterization of Normal and Tumor-Invaded Lymph Nodes in a Rabbit Model
Am. J. Roentgenol., December 1, 2002; 179(6): 1567 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. G. Ruehm, T. Schroeder, and J. F. Debatin
Interstitial MR Lymphography with Gadoterate Meglumine: Initial Experience in Humans
Radiology, September 1, 2001; 220(3): 816 - 821.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. Staatz, C. C. A. Nolte-Ernsting, G. B. Adam, S. Grosskortenhaus, B. Misselwitz, A. Bucker, and R. W. Gunther
Interstitial T1-weighted MR Lymphography: Lipophilic Perfluorinated Gadolinium Chelates in Pigs
Radiology, July 1, 2001; 220(1): 129 - 134.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. G. Ruehm, C. Corot, and J. F. Debatin
Interstitial MR Lymphography with a Conventional Extracellular Gadolinium-based Agent: Assessment in Rabbits
Radiology, March 1, 2001; 218(3): 664 - 669.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Roentgen Ray Society.